These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 31979298)
21. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219 [TBL] [Abstract][Full Text] [Related]
22. Triple stimuli-responsive keratin nanoparticles as carriers for drug and potential nitric oxide release. Li Y; Lin J; Zhi X; Li P; Jiang X; Yuan J Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():606-614. PubMed ID: 30033293 [TBL] [Abstract][Full Text] [Related]
23. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo. Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887 [TBL] [Abstract][Full Text] [Related]
24. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency. Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396 [TBL] [Abstract][Full Text] [Related]
28. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
29. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells. Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813 [TBL] [Abstract][Full Text] [Related]
30. AIE/FRET-based versatile PEG-Pep-TPE/DOX nanoparticles for cancer therapy and real-time drug release monitoring. Wang TT; Wei QC; Zhang ZT; Lin MT; Chen JJ; Zhou Y; Guo NN; Zhong XC; Xu WH; Liu ZX; Han M; Gao JQ Biomater Sci; 2020 Jan; 8(1):118-124. PubMed ID: 31777865 [TBL] [Abstract][Full Text] [Related]
31. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation. Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776 [TBL] [Abstract][Full Text] [Related]
33. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421 [TBL] [Abstract][Full Text] [Related]
34. Chemotherapeutic Delivery from a Self-Assembling Peptide Nanofiber Hydrogel for the Management of Glioblastoma. Karavasili C; Panteris E; Vizirianakis IS; Koutsopoulos S; Fatouros DG Pharm Res; 2018 Jun; 35(8):166. PubMed ID: 29943122 [TBL] [Abstract][Full Text] [Related]
35. pH-triggered morphological change in a self-assembling amphiphilic peptide used as an antitumor drug carrier. Gong Z; Liu X; Wu J; Li X; Tang Z; Deng Y; Sun X; Chen K; Gao Z; Bai J Nanotechnology; 2020 Apr; 31(16):165601. PubMed ID: 31891937 [TBL] [Abstract][Full Text] [Related]
36. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect. Song Y; Tang C; Yin C Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548 [TBL] [Abstract][Full Text] [Related]
37. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles. Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221 [TBL] [Abstract][Full Text] [Related]
38. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin. Yang S; Tang Z; Zhang D; Deng M; Chen X Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292 [TBL] [Abstract][Full Text] [Related]
39. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles. Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530 [TBL] [Abstract][Full Text] [Related]